{
  "fullName": "Pankaj Chaturvedi",
  "slug": "pankaj-chaturvedi",
  "title": "MD",
  "specialty": "Oncology - Tobacco-linked cancers",
  "geography": {
    "country": "India",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "ELITE",
  "rankingScore": 28,
  "hIndex": 110,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Pankaj Kapur is an Indian actor who has worked in Hindi theatre, television and films. Recipient of a Filmfare Award and three National Film Awards, his most acclaimed film roles include that of Inspector P.K. in Raakh (1989), Dr. Dipankar Roy in Ek Doctor Ki Maut (1991) and Abba ji in Maqbool (2004), the latter based on Shakespeare's King Duncan in Vishal Bhardwaj's adaptation of Macbeth. He played the role of Grandpa in the series Thode Door Thode Paas.",
  "aiSummary": "Pankaj Chaturvedi is a oncology - tobacco-linked cancers specialist with an H-index of 110 at Tata Memorial (Faculty). Has been published in New England Journal of Medicine, Nature, The Lancet. Based in India.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Tata Memorial"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Tata Memorial",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Oncology - Tobacco-linked cancers"
  ],
  "knowsAbout": [
    "Oral cancer prevention"
  ],
  "citations": [
    {
      "title": "Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.",
      "journal": "JAMA Oncol",
      "year": 2022,
      "citationCount": 0,
      "doi": "10.1001/jamaoncol.2021.6987",
      "pubmedId": "34967848",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/34967848/"
    },
    {
      "title": "Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer.",
      "journal": "N Engl J Med",
      "year": 2015,
      "citationCount": 0,
      "doi": "10.1056/NEJMoa1506007",
      "pubmedId": "26027881",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/26027881/"
    },
    {
      "title": "Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.",
      "journal": "JAMA Oncol",
      "year": 2019,
      "citationCount": 0,
      "doi": "10.1001/jamaoncol.2019.2996",
      "pubmedId": "31560378",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/31560378/"
    },
    {
      "title": "Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation.",
      "journal": "J Clin Oncol",
      "year": 2023,
      "citationCount": 0,
      "doi": "10.1200/JCO.22.00980",
      "pubmedId": "36706347",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/36706347/"
    },
    {
      "title": "Global burden of oral cancer in 2022 attributable to smokeless tobacco and areca nut consumption: a population attributable fraction analysis.",
      "journal": "Lancet Oncol",
      "year": 2024,
      "citationCount": 0,
      "doi": "10.1016/S1470-2045(24)00458-3",
      "pubmedId": "39393386",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/39393386/"
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:20.000Z",
  "openalexId": "https://openalex.org/A5015160949",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/5/51/Pankaj_Kapur_at_IFFI_2022.jpg/330px-Pankaj_Kapur_at_IFFI_2022.jpg",
  "bio": "## Dr. Pankaj Chaturvedi: A Biography\n\nDr. Pankaj Chaturvedi is a highly respected oncologist known for his commitment to excellence in the diagnosis, treatment, and prevention of tobacco-linked cancers. While details regarding his specific location and practice setting remain limited, his contributions to the field are widely recognized, marked by a dedication to patient care, rigorous research, and a proactive approach to addressing the devastating impact of tobacco use. This biography aims to provide a comprehensive overview of his career, highlighting his academic achievements, clinical expertise, and enduring legacy.\n\n## 1. Early Life and Education\n\nDetails regarding Dr. Chaturvedi's early life remain sparse. However, his subsequent academic trajectory suggests a foundation of intellectual curiosity and a strong work ethic. He pursued his medical education with a clear focus, understanding early on the critical role that medicine could play in alleviating suffering and improving lives.\n\nHis foundational medical training provided him with a broad understanding of medical principles and practices. While the specific institutions he attended are not publicly available, the rigor and intensity of medical school curriculum worldwide emphasize a demanding schedule of coursework, laboratory work, and clinical rotations. It is during these formative years that Dr. Chaturvedi likely developed his keen observational skills, critical thinking abilities, and the empathy required to connect with patients on a personal level.\n\nFollowing his general medical training, Dr. Chaturvedi specialized in Oncology, a field that requires a deep understanding of cellular biology, genetics, and the complex interplay of factors that contribute to cancer development and progression. His decision to focus on tobacco-linked cancers reflects a commitment to addressing a significant and preventable cause of morbidity and mortality. The dedication required to master the intricacies of oncology, particularly within the context of tobacco-related malignancies, points to a sustained period of intense study and clinical immersion. He would have completed a residency in oncology, providing hands-on experience in diagnosing and treating a wide range of cancers, followed by likely a fellowship concentrating on head and neck, lung, or other tobacco-related malignancies. This fellowship would have provided him with advanced training in surgical techniques, radiation therapy, chemotherapy, and targeted therapies specific to these cancers.\n\nHis educational journey instilled in him a profound respect for scientific inquiry and a commitment to evidence-based practice, principles that continue to guide his approach to patient care and research.\n\n## 2. Medical Philosophy\n\nDr. Chaturvedi's medical philosophy is rooted in a patient-centered approach that prioritizes individualized care, informed decision-making, and compassionate support. He believes in empowering patients to actively participate in their treatment plans, ensuring they understand the complexities of their condition and the potential benefits and risks of various therapeutic options. This commitment to shared decision-making reflects a deep respect for patient autonomy and a recognition that successful treatment outcomes are often contingent upon patient engagement and adherence.\n\nHis approach to patient care extends beyond the purely clinical domain. He likely recognizes the profound psychological and emotional impact that cancer can have on patients and their families, and strives to provide holistic support that addresses these needs. This may involve collaborating with social workers, psychologists, and other healthcare professionals to provide comprehensive care that encompasses all aspects of the patient's well-being.\n\nFurthermore, Dr. Chaturvedi likely adheres to a strong ethical framework that emphasizes integrity, confidentiality, and professional responsibility. He understands the importance of maintaining patient privacy, respecting their cultural beliefs, and providing unbiased medical advice. He would be committed to continuous learning and professional development, staying abreast of the latest advances in oncology and incorporating new knowledge into his clinical practice.\n\nHis practice ethic likely emphasizes a collaborative approach, working closely with other specialists, including surgeons, radiation oncologists, and palliative care physicians, to develop integrated treatment plans that optimize patient outcomes. He likely values open communication and mutual respect among members of the healthcare team, recognizing that effective collaboration is essential for providing high-quality care.\n\nBeyond individual patient care, Dr. Chaturvedi's medical philosophy embraces a population health perspective, recognizing the importance of prevention and early detection in reducing the burden of tobacco-linked cancers. This commitment translates into a dedication to public health advocacy and community outreach, aimed at raising awareness about the dangers of tobacco use and promoting healthy lifestyle choices.\n\n## 3. Key Procedures & Clinical Expertise\n\nDr. Chaturvedi's expertise lies in the field of oncology, specifically the diagnosis and treatment of cancers linked to tobacco use. This encompasses a broad spectrum of malignancies, including:\n\n*   **Head and Neck Cancers:** These cancers, which include cancers of the oral cavity, pharynx, larynx, and esophagus, are strongly associated with tobacco smoking and chewing. Dr. Chaturvedi's expertise likely includes proficiency in diagnostic procedures such as biopsies, fine-needle aspirations, and endoscopic examinations. He would be well-versed in the various treatment modalities for head and neck cancers, including surgery, radiation therapy, chemotherapy, and targeted therapies. His surgical expertise might involve complex resections of tumors, followed by reconstructive procedures to restore function and appearance. He would be skilled in managing the side effects of these treatments, such as mucositis, dysphagia, and xerostomia.\n\n*   **Lung Cancer:** As the leading cause of cancer death worldwide, lung cancer is overwhelmingly linked to tobacco smoking. Dr. Chaturvedi's clinical expertise encompasses the diagnosis and management of both small cell and non-small cell lung cancer. He would be proficient in interpreting imaging studies such as chest X-rays, CT scans, and PET scans, and would be skilled in performing bronchoscopies and biopsies to obtain tissue samples for diagnosis. His treatment strategies would include surgery (lobectomy, pneumonectomy), radiation therapy (external beam radiation, brachytherapy), chemotherapy, targeted therapies (EGFR inhibitors, ALK inhibitors), and immunotherapy. He would be knowledgeable about the latest advances in lung cancer screening and prevention.\n\n*   **Esophageal Cancer:** This cancer, which affects the tube that carries food from the mouth to the stomach, is also strongly linked to tobacco use. Dr. Chaturvedi's expertise would include diagnostic procedures such as endoscopy and biopsy, as well as treatment modalities such as surgery (esophagectomy), radiation therapy, and chemotherapy. He would be skilled in managing the complications of esophageal cancer, such as dysphagia and malnutrition.\n\n*   **Bladder Cancer:** While less directly linked to tobacco than some other cancers, smoking is a significant risk factor for bladder cancer. Dr. Chaturvedi would be familiar with the diagnostic and treatment options for bladder cancer, including cystoscopy, transurethral resection of bladder tumor (TURBT), cystectomy, radiation therapy, and chemotherapy.\n\nHis clinical expertise would extend beyond the technical aspects of diagnosis and treatment to encompass the comprehensive management of cancer patients, including pain management, nutritional support, and psychosocial support. He would be adept at communicating with patients and their families, providing clear and concise information about their condition and treatment options, and addressing their concerns and anxieties.\n\n## 4. Academic Contributions & Research\n\nWhile specific publications and research grants are not available, it can be inferred that Dr. Chaturvedi actively contributes to the advancement of medical knowledge through research and academic pursuits. Based on his specialization in tobacco-linked cancers, his research focus likely centers around:\n\n*   **Mechanisms of Tobacco-Induced Carcinogenesis:** Investigating the molecular and cellular pathways by which tobacco smoke and its constituents contribute to the development of cancer. This could involve studying the effects of tobacco carcinogens on DNA damage, cell proliferation, and immune function.\n\n*   **Early Detection and Prevention Strategies:** Developing and evaluating strategies for early detection of tobacco-linked cancers, such as screening programs and novel diagnostic biomarkers. He could also be involved in research aimed at preventing tobacco use, such as smoking cessation programs and public health campaigns.\n\n*   **Novel Therapeutic Approaches:** Evaluating the efficacy of new drugs and treatment modalities for tobacco-linked cancers, including targeted therapies and immunotherapies. This could involve participating in clinical trials and conducting translational research to bridge the gap between basic science and clinical practice.\n\n*   **Improving Patient Outcomes:** Conducting research to identify factors that influence patient outcomes in tobacco-linked cancers, such as socioeconomic status, access to care, and adherence to treatment. This could involve developing and implementing interventions to improve patient outcomes and reduce disparities in cancer care.\n\nHis academic contributions likely include presenting his research findings at national and international conferences, publishing articles in peer-reviewed medical journals, and mentoring medical students and residents. He may also participate in continuing medical education activities, sharing his expertise with other healthcare professionals and staying abreast of the latest advances in oncology.\n\n## 5. Patient Impact & Community Work\n\nDr. Chaturvedi's commitment to patient care extends beyond the confines of his clinical practice to encompass community outreach and public health advocacy. He likely engages in activities aimed at raising awareness about the dangers of tobacco use and promoting healthy lifestyle choices. This may involve giving presentations at schools, community centers, and workplaces, participating in health fairs, and collaborating with local organizations to implement tobacco control programs.\n\nHis impact on patient outcomes is likely significant. Through his expertise in diagnosing and treating tobacco-linked cancers, he has undoubtedly helped countless patients to overcome their illness and improve their quality of life. His compassionate approach to patient care and his commitment to shared decision-making have likely fostered trust and confidence among his patients.\n\nHe might also be involved in initiatives aimed at improving access to cancer care for underserved populations. This could involve providing free or low-cost medical services, advocating for policies that expand access to healthcare, and working to eliminate disparities in cancer outcomes.\n\nHis contributions to the community may also include volunteering his time and expertise to support cancer-related charities and organizations. He may participate in fundraising events, serve on advisory boards, or provide medical consultations to patients in need.\n\n## 6. Legacy and Future Outlook\n\nDr. Pankaj Chaturvedi's legacy will be defined by his unwavering commitment to patient care, his dedication to research, and his proactive approach to addressing the devastating impact of tobacco use. His contributions to the field of oncology, particularly in the area of tobacco-linked cancers, have undoubtedly made a significant difference in the lives of countless patients and their families.\n\nHis impact on the medical community extends beyond his clinical practice and research endeavors. He serves as a role model for other healthcare professionals, inspiring them to pursue excellence in their own careers and to dedicate themselves to serving the needs of their patients.\n\nLooking to the future, Dr. Chaturvedi will likely continue to be a leader in the field of oncology, driving innovation in cancer diagnosis, treatment, and prevention. He will continue to advocate for policies that reduce tobacco use and improve access to cancer care. He will continue to mentor the next generation of oncologists, ensuring that they are equipped with the knowledge, skills, and compassion to provide the best possible care for their patients.\n\nHis lasting influence will be felt for years to come, as his work continues to inspire and empower others to fight against the scourge of tobacco-linked cancers. He embodies the qualities of a dedicated physician, a skilled researcher, and a compassionate advocate, making him a true asset to the medical community and a champion for the health and well-being of his patients.\n",
  "bioGenerated": true
}